Neurocrine Bio. (NBIX) PT Raised to $135 at Barclays
Get Alerts NBIX Hot Sheet
Price: $174.26 +3.87%
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
Barclays raised its price target on Neurocrine Bio. (NASDAQ: NBIX) to $135.00 (from $100.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Bajaj Housing Finance (BAJAJHFL:IN) to Neutral
- Ajinomoto (2802:JP) (AJINY) PT Raised to JPY5,800 at Nomura/Instinet
- Daito Trust Construction Co Ltd. (1878:JP) (DIFTY) PT Lowered to JPY3,570 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share